Impact of hepatitis B immunisation as part of the EPI

Since 1992, hepatitis B vaccine has been an integrated part of Thailand's expanded programme on immunisation (EPI). Based on the data from five representative provinces, we have evaluated its impact on the countrywide prevalence of HBV infection and carrier rate. The population studied comprise...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2000-11, Vol.19 (7), p.943-949
Hauptverfasser: Poovorawan, Yong, Theamboonlers, Apiradee, Vimolket, Thosporn, Sinlaparatsamee, Supakarn, Chaiear, Kasemporn, Siraprapasiri, Taweesap, Khwanjaipanich, Sawan, Owatanapanich, Somchai, Hirsch, Petra, Chunsuttiwat, Supamit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Since 1992, hepatitis B vaccine has been an integrated part of Thailand's expanded programme on immunisation (EPI). Based on the data from five representative provinces, we have evaluated its impact on the countrywide prevalence of HBV infection and carrier rate. The population studied comprised 400–488 healthy and immuno-competent, subjects per area. The subjects’ ages ranged from 6 months to 18 years. We examined their sera for viral hepatitis markers using commercially available test kits and established the coverage rate of hepatitis B vaccination after its inclusion into the EPI to be 71.2–94.3%. The number of individuals undergoing the complete course of vaccinations had increased four-fold. Consequently, only 0.7% of the children born after the implementation of this the novel EPI strategy were HBV carriers.
ISSN:0264-410X
1873-2518
DOI:10.1016/S0264-410X(00)00216-4